ClariVest Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $6.49K | Hold |
12
| – | – | ﹤0.01% | 432 |
|
|
2024
Q2 | $6.49K | Sell |
12
-29
| -71% | -$15.3K | ﹤0.01% | 432 |
|
|
2024
Q1 | $21.3K | Buy |
41
+7
| +21% | +$3.48K | ﹤0.01% | 382 |
|
|
2023
Q4 | $16K | Buy |
34
+1
| +3% | +$462 | ﹤0.01% | 385 |
|
|
2023
Q3 | $14K | Sell |
33
-1
| -3% | -$454 | ﹤0.01% | 379 |
|
|
2023
Q2 | $15K | Sell |
34
-2
| -6% | -$923 | ﹤0.01% | 372 |
|
|
2023
Q1 | $16K | Sell |
36
-1
| -3% | -$476 | ﹤0.01% | 434 |
|
|
2022
Q4 | $19K | Hold |
37
| – | – | ﹤0.01% | 441 |
|
|
2022
Q3 | $17K | Buy |
37
+4
| +12% | +$1.91K | ﹤0.01% | 438 |
|
|
2022
Q2 | $16K | Buy |
+33
| New | +$16.3K | ﹤0.01% | 452 |
|
|
2022
Q1 | – | Sell |
-33
| Closed | -$16K | – | 742 |
|
|
2021
Q4 | $16K | Buy |
33
+2
| +6% | +$841 | ﹤0.01% | 494 |
|
|
2021
Q3 | $11K | Sell |
31
-541
| -95% | -$206K | ﹤0.01% | 524 |
|
|
2021
Q2 | $219K | Buy |
572
+6
| +1% | +$2.29K | 0.01% | 476 |
|
|
2021
Q1 | $203K | Sell |
566
-100
| -15% | -$32.2K | 0.01% | 473 |
|
|
2020
Q4 | $214K | Sell |
666
-200
| -23% | -$61.4K | 0.01% | 486 |
|
|
2020
Q3 | $233K | Sell |
866
-100
| -10% | -$26.9K | 0.01% | 436 |
|
|
2020
Q2 | $254K | Sell |
966
-10
| -1% | -$2.67K | 0.01% | 501 |
|
|
2020
Q1 | $222K | Sell |
976
-2
| -0.2% | -$545 | 0.01% | 478 |
|
|
2019
Q4 | $296K | Sell |
978
-103
| -10% | -$28.3K | 0.01% | 455 |
|
|
2019
Q3 | $259K | Buy |
1,081
+598
| +124% | +$164K | 0.01% | 476 |
|
|
2019
Q2 | $136K | Hold |
483
| – | – | ﹤0.01% | 454 |
|
|
2019
Q1 | $139K | Sell |
483
-159
| -25% | -$46K | ﹤0.01% | 531 |
|
|
2018
Q4 | $169K | Buy |
642
+43
| +7% | +$11.8K | ﹤0.01% | 554 |
|
|
2018
Q3 | $165K | Hold |
599
| – | – | ﹤0.01% | 607 |
|
|
2018
Q2 | $143K | Sell |
599
-31
| -5% | -$7.18K | ﹤0.01% | 631 |
|
|
2018
Q1 | $139K | Buy |
630
+566
| +884% | +$133K | ﹤0.01% | 633 |
|
|
2017
Q4 | $15K | Hold |
64
| – | – | ﹤0.01% | 630 |
|
|
2017
Q3 | $12K | Hold |
64
| – | – | ﹤0.01% | 548 |
|
|
2017
Q2 | $12K | Buy |
+64
| New | +$11.5K | ﹤0.01% | 569 |
|
|
2016
Q4 | – | Sell |
-2,452
| Closed | -$307K | – | 682 |
|
|
2016
Q3 | $307K | Sell |
2,452
-1,477
| -38% | -$191K | 0.01% | 447 |
|
|
2016
Q2 | $516K | Sell |
3,929
-317
| -7% | -$43.4K | 0.02% | 362 |
|
|
2016
Q1 | $590K | Sell |
4,246
-3
| -0.1% | -$401 | 0.02% | 342 |
|
|
2015
Q4 | $593K | Sell |
4,249
-4,502
| -51% | -$620K | 0.02% | 334 |
|
|
2015
Q3 | $1.23M | Sell |
8,751
-622
| -7% | -$93.5K | 0.04% | 248 |
|
|
2015
Q2 | $1.54M | Hold |
9,373
| – | – | 0.05% | 242 |
|
|
2015
Q1 | $1.45M | Sell |
9,373
-1,170
| -11% | -$167K | 0.04% | 247 |
|
|
2014
Q4 | $1.32M | Buy |
10,543
+8,995
| +581% | +$1.11M | 0.05% | 203 |
|
|
2014
Q3 | $186K | Buy |
1,548
+484
| +45% | +$55.5K | 0.01% | 373 |
|
|
2014
Q2 | $115K | Buy |
1,064
+514
| +93% | +$53K | ﹤0.01% | 409 |
|
|
2014
Q1 | $55K | Sell |
550
-150
| -21% | -$13.6K | ﹤0.01% | 444 |
|
|
2013
Q4 | $64K | Buy |
700
+450
| +180% | +$40K | ﹤0.01% | 465 |
|
|
2013
Q3 | $21K | Hold |
250
| – | – | ﹤0.01% | 446 |
|
|
2013
Q2 | $20K | Buy |
+250
| New | +$18.7K | ﹤0.01% | 410 |
|
Other funds holding ELV
ClariVest Asset Management's ELV Position: Q3 2024 in Review
ClariVest Asset Management held its Elevance Health (ELV) position steady in Q3 2024 at 12 shares worth $6.49K. The position accounts for ﹤0.01% of the portfolio, ranked #432.
ClariVest Asset Management first reported a position in ELV in Q2 2013 and has held it in 43 quarters since. The position peaked at $1.54M in Q2 2015. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.
- ClariVest Asset Management held 12 shares of Elevance Health worth $6.49K as of Q3 2024.
- ClariVest Asset Management left its Elevance Health share count unchanged in Q3 2024.
- Elevance Health made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #432 holding.
- ClariVest Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 43 quarters since.
- ClariVest Asset Management's Elevance Health position peaked at $1.54M in Q2 2015.
- 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.
Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.